FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to experimental medicine, namely to pharmacology. The object in view is achieved by the fact that 0.5% humic acids additionally containing magnesium sulphate (II) are applied as a diuretic in the following proportions: 0.5% humic acids - 40 ml; magnesium sulphate - 0.1 g.
EFFECT: higher clinical effectiveness and eliminated side effects.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
DIURETIC | 2016 |
|
RU2619348C1 |
MEANS WITH DIURETIC ACTIVITY | 2016 |
|
RU2624851C1 |
DIURETIC | 2016 |
|
RU2619346C1 |
AGENTS WITH DIURETIC ACTIVITY | 2016 |
|
RU2619350C1 |
AGENT WITH DIURETIC ACTIVITY | 2016 |
|
RU2619349C1 |
DRUG PREPARATION POSSESSING DIURETIC ACTIVITY | 2011 |
|
RU2485966C1 |
METHOD FOR SIMULATING POST-ISCHEMIC RENAL INSUFFICIENCY | 2012 |
|
RU2481646C1 |
USE OF PINOSTROBIN AS DIURETIC AND CREATINURETIC AGENT | 2023 |
|
RU2816948C1 |
PROCESS FOR PREPARATION OF A SUBSTANCE HAVING A DIURETIC ACTIVITY | 2017 |
|
RU2671408C1 |
USE OF PINOCEMBRIN AS DIURETIC AND CREATININURETIC AGENT | 2023 |
|
RU2822937C1 |
Authors
Dates
2012-07-20—Published
2011-03-16—Filed